Luteal vs Follicular Surgical Oophorectomy and Tamoxifen in Premenopausal Women With Metastatic Hormone Receptor Positive Breast Cancer

Completed · Phase 3

Conditions studied: Breast Cancer

In brief

This study will determine if hormone receptor positive premenopausal metastatic breast cancer patients who undergo removal of the ovaries in mid-luteal versus mid-follicular phase have a longer survival.

Key facts

Study ID

NCT00293540

Run by

International Breast Cancer Research Foundation

People needed

249

Starts

2006-02-01

Expected to finish

2015-03-01

Last updated by the study team

2016-07-27

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Estrogen receptor or progesterone receptor positive breast cancer
• Premenopausal with regular menstrual cycles

You may not qualify if…

• Current oral contraceptives

Where it is running

• Ohio State University — Columbus, Ohio, United States
• Dhaka Medical College Hospital — Dhaka, Bangladesh
• 4th Hospital of Hebei Medical University — Shijiazhuang, Hebei, China
• Beijing Hospital — Beijing, China
• Cancer Institute — Beijing, China
• Choa Yang Capital Institute — Beijing, China
• National Railroad — Beijing, China
• Peoples Hospital — Beijing, China
• Qilu Hospital — Jinan, China
• Fudan University — Shanghai, China
• Nizam's Institute — Hyderabaad, India
• Dr. Ciptomanounkusumo General Hospital — Jakarta, Indonesia
• UN. Mayala — Kuala Lumpur, Malaysia
• National Institute of Oncology — Rabat, Morocco
• University College Hospital — Ibadan, Nigeria
• East Avenue Medical Center — Manila, Philippines
• Jose Reyes — Manila, Philippines
• Philippines General Hospital — Manila, Philippines
• Rizal — Manila, Philippines
• Vicente Sotto Hospital — Manila, Philippines
• Hospital K — Hanoi, Vietnam

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.